tiprankstipranks
Trending News
More News >
Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
US Market
Advertisement

Monte Rosa Therapeutics (GLUE) Technical Analysis

Compare
325 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
4Neutral
4Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Monte Rosa Therapeutics’s (GLUE) Moving Averages Convergence Divergence (MACD) indicator is 0.55, suggesting Monte Rosa Therapeutics is a Sell.
Monte Rosa Therapeutics’s (GLUE) 20-Day exponential moving average is 5.99, while Monte Rosa Therapeutics’s (GLUE) share price is $7.49, making it a Buy.
Monte Rosa Therapeutics’s (GLUE) 50-Day exponential moving average is 5.43, while Monte Rosa Therapeutics’s (GLUE) share price is $7.49, making it a Buy.

Monte Rosa Therapeutics (GLUE) Pivot Points

Sep 27, 2025, 03:23 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.13
6.26
6.40
6.53
6.67
6.80
6.94
Fibonacci
6.26
6.36
6.42
6.53
6.63
6.69
6.80
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Monte Rosa Therapeutics (GLUE) Moving Averages

Sep 27, 2025, 03:23 PM
Period
Simple
Exponential
MA5
6.70Buy
6.82Buy
MA10
6.65Buy
6.48Buy
MA20
5.76Buy
5.99Buy
MA50
5.25Buy
5.43Buy
MA100
4.92Buy
5.28Buy
MA200
5.45Buy
5.72Buy
Monte Rosa Therapeutics’s (GLUE) 10-Day exponential moving average is 6.48, while Monte Rosa Therapeutics’s (GLUE) share price is $7.49, making it a Buy.
Monte Rosa Therapeutics’s (GLUE) 100-Day exponential moving average is 5.28, while Monte Rosa Therapeutics’s (GLUE) share price is $7.49, making it a Buy.
Monte Rosa Therapeutics’s (GLUE) stock price is $7.49 and Monte Rosa Therapeutics’s (GLUE) 50-day simple moving average is 5.25, creating a Buy signal.
Monte Rosa Therapeutics’s (GLUE) stock price is $7.49 and Monte Rosa Therapeutics’s (GLUE) 100-day simple moving average is 4.92, creating a Buy signal.
Monte Rosa Therapeutics’s (GLUE) stock price is $7.49 and Monte Rosa Therapeutics’s (GLUE) 200-day simple moving average is 5.45, creating a Buy signal.

Monte Rosa Therapeutics (GLUE) Technical Indicators

Sep 27, 2025, 03:23 PM
Name
Value
Implied Action
RSI (14)
70.50
Sell
STOCH (9,6)
67.67
Neutral
STOCHRSI (14)
78.25
Neutral
MACD (12,26)
0.55
Sell
ADX (14)
46.17
Neutral
Williams %R
-0.74
Sell
CCI (14)
106.88
Sell
ATR (14)
0.48
-
Ultimate Oscillator
61.13
Neutral
ROC
56.04
Buy
Monte Rosa Therapeutics’s (GLUE) Relative Strength Index (RSI) is 70.50, creating a Sell signal.
Monte Rosa Therapeutics’s (GLUE) Trend Strength Indicator (ADX) is 46.17, creating a Neutral signal.
Monte Rosa Therapeutics’s (GLUE) Commodity Channel Index (CCI) is 106.88, creating a Sell signal.
Monte Rosa Therapeutics’s (GLUE) Price Rate of Change (ROC) is 56.04, creating a Buy signal.

FAQ

Is GLUE a Buy, Hold, or Sell?
Based on GLUE’s technical indicators, GLUE is a Buy.
    What is GLUE’s RSI (14)?
    GLUE’s RSI (14) is 70.50, which suggests GLUE is a Sell.
      What is GLUE’s MACD?
      GLUE’s MACD is 0.55, which suggests GLUE is a Sell.
        What is GLUE’s 5-day moving average?
        GLUE’s 5-day moving average is 6.70, which suggests GLUE is a Buy.
          What is GLUE’s 20-day moving average?
          GLUE 20-day moving average is 5.76, which suggests GLUE is a Buy.
            What is GLUE’s 50-day moving average?
            GLUE’s 50-day moving average is 5.25, which suggests GLUE is a Buy.
              What is GLUE’s 200-day moving average?
              GLUE’s 200-day moving average is 5.45, which suggests GLUE is a Buy.
                What is GLUE’s Williams % R (14)?
                GLUE’s Williams % R (14) is -0.74, which suggests GLUE is a Sell.
                  What is GLUE’s CCI (14)?
                  GLUE’s CCI (14) is 106.88, which suggests GLUE is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis